TIF applauds new thalassaemia therapy
The Cyprus-based Thalassaemia International Federation (TIF) on Friday hailed the landmark announcement by UK regulators approving a revolutionary gene-editing treatment for beta thalassemia and sickle-cell disease “and ushering in a ...